Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Haloperidol plasma and red blood cell levels and clinical antipsychotic response.

Garver DL, Hirschowitz J, Glicksteen GA, Kanter DR, Mavroidis ML.

J Clin Psychopharmacol. 1984 Jun;4(3):133-7.

PMID:
6736272
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
3.

Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.

Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.

J Psychiatry Neurosci. 1994 Jul;19(4):254-64. Review.

4.

Review of haloperidol blood level and clinical response: looking through the window.

Volavka J, Cooper TB.

J Clin Psychopharmacol. 1987 Feb;7(1):25-30. Review.

PMID:
3546403
5.

Haloperidol plasma level monitoring in neuropsychiatric patients.

Morselli PL, Bianchetti G, Dugas M.

Ther Drug Monit. 1982;4(1):51-8. Review.

PMID:
7041338
6.

Plasma level monitoring of antipsychotic drugs. Clinical utility.

Dahl SG.

Clin Pharmacokinet. 1986 Jan-Feb;11(1):36-61. Review.

PMID:
2868820
Items per page

Supplemental Content

Write to the Help Desk